Abstract:Background: The development and metastasis of cancer cells are regulated by tumor-associated macrophages (TAMs) present in the surrounding tumor microenvironment. RIG-I is a key pathogen recognition receptor against RNA viruses that regulates innate immunity in cancer progression. Till now, the mechanism of RIG-I regulation of the polarization of TAMs in the progression of hepatocellular carcinoma (HCC) has not been understood. Materials and Methods: Levels of RIG-I and the key proteins in the NF-kappa B pathway in HCC and paired paracancerous tissues were detected by Western blotting. The transfection efficiency of RIG-I was observed by fluorescence microscopy. The M1 and M2 markers were detected by real-time polymerase chain reaction and FACS assays. Apoptosis of RIG-I lentivirus-infected HCC cells was detected by flow cytometry assay. Death of Hepal-6 and H22 cells was analyzed by lactate dehydrogenase releasing assay. Results: The level of RIG-I was decreased in HCC tissues as compared to that in the paired paracancerous tissues. Overexpression of RIG-I in mouse peritoneal macrophages increased the expression of the biomarkers CD16/32 and CD11c associated with M1 macrophages. The relative levels of IL-1 beta, TNF-alpha, IL-6, and iNOS were significantly increased in RIG-I lentivirus-infected macrophages, whereas the levels of Arg-1 and IL-10 were not significantly different in RIG-I-overexpressed peritoneal macrophages. Moreover, overexpression of RIG-I in peritoneal macrophages promoted apoptosis of Hepal-6 and H22 cells. Furthermore, overexpression of RIG-I increased the levels of phosphorylated p65 and p-I kappa B and decreased the level of I kappa B in peritoneal macrophages. Importantly, the expression of MAVS and TRAF2 was significantly increased in RIG-I lentivirus-infected macrophages. Conclusion: Our results demonstrate that overexpression of RIG-I promoted apoptosis and death of HCC cells. Moreover, RIG-I promoted the polarization of M1 through the RIG-I/MAVS/TRAF2/NF-kappa B pathway in mice peritoneal macrophages, suggesting that RIG-I may be a novel target in the immunotherapy of HCC.

RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination

O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation

Mutant RIG-I enhances cancer-related inflammation through activation of circRIG-I signaling

RIG-I Promotes Cell Viability, Colony Formation, and Glucose Metabolism and Inhibits Cell Apoptosis in Colorectal Cancer by NF-κB Signaling Pathway

Rigosertib Promotes Anti-Tumor Immunity Via Autophagic Degradation of PD-L1 in Colorectal Cancer Cells

Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I

Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells

RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer

RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity

Rig-I Suppresses The Migration And Invasion Of Hepatocellular Carcinoma Cells By Regulating Mmy9

Demethylase JMJD2D induces PD-L1 expression to promote colorectal cancer immune escape by enhancing IFNGR1-STAT3-IRF1 signaling

Riluzole Enhancing anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer

RIG-I Promotes Cell Death in Hepatocellular Carcinoma by Inducing M1 Polarization of Perineal Macrophages Through the RIG-I/MAVS/NF-κB Pathway.

Retinoic Acid-Inducible Gene-I Like Receptor Pathway in Cancer: Modification and Treatment

Tumor Suppressor Activity of RIG-I

RIG-I Promotes Cell Proliferation in Esophageal Squamous Cell Carcinoma by Facilitating P21 Degradation.

RIG-I Acts As a Tumor Suppressor in Melanoma Via Regulating the Activation of the MKK/p38MAPK Signaling Pathway.

The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer

Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry

Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation

Polymeric Immunoglobulin Receptor Suppresses Colorectal Cancer Through the AKT-FOXO3/4 Axis by Downregulating LAMB3 Expression